Name | Title | Contact Details |
---|
Bioject Medical Technologies Inc. is a leader in the development of needle-free injection therapies with over 25 years of experience improving the administration of liquid medications; pharmaceuticals, vaccines, and biologics. Bioject's technology works by forcing liquid medication at high speed through a tiny orifice held against the skin. This creates an ultra-fine stream of fluid that penetrates the skin, delivering medication in a fraction of a second. Bioject's systems are designed to deliver injected medications comfortably, accurately, and quickly - without the use of a needle. Bioject was founded in 1985 to develop needle-free injection systems to improve the comfort and safety of routine injections. From its early work focused on improving the characteristics of these delivery systems, the Company has created a broad technology platform for delivering a wide range of medications and vaccines to the subcutaneous, intramuscular and intradermal depths. Bioject has developed a portfolio of injection systems based on its core technology, the foundation for which is more than 80 issued and pending patents and an extensive body of technical know-how. These include durable devices designed for heavy use in a professional healthcare environment, and small, lightweight injectors designed for home use. With partners, Bioject is also developing inexpensive, pre-filled, disposable injection systems. Further validating its technology, Bioject and its partners have the largest volume of published studies using needle-free injection technology systems. Bioject's strategy is to form strategic partnerships with pharmaceutical, biotechnology, and animal health companies. The result is mutually beneficial agreements with these partners to develop customized injection systems to enhance the delivery of their injected medication or vaccine. Bioject has alliances with leading pharmaceutical, biotechnology, and animal health companies. Bioject's products are also used in public health, Physicians offices, and in cutting edge biomedical research at leading institutions around the globe.
Cellomics, Inc. is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Diagnostic Corporation is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Symmetry Surgical is dedicated to developing high-quality surgical instruments that respond to clinicians` needs as they arise, making a real difference in the lives of patients. Our broad portfolio also brings together the rich history and distinctive product lines of the recently acquired stainless steel and titanium surgical instruments of Codman, the surgical instruments of Specialty Surgical Instrumentation (SSI) and the electrosurgery instruments of Olsen Medical. Offering one of the most comprehensive suites of surgical instruments in the industry, we continue to collaborate with clinicians, global medical device manufacturers and thousands of hospitals to provide solutions for today`s needs and tomorrow`s growth. Headquartered just outside of Nashville, TN, Symmetry Surgical is a wholly owned subsidiary of Symmetry Medical Inc.(NYSE:SMA).
Innova Medical Group is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions. Our strategic and iterative approach enables us to create, build and deploy a myriad of accessible tests customized to meet and empower the user at their point of need. With a panoramic vision spanning the present to the future, we develop trusted solutions that are both intuitive and secure to use. We quickly and nimbly became the world`s largest provider of COVID-19 tests, and we are determined to execute on this model across infectious disease, other chronic conditions and wellness.